Futurity: COVID Test Identifies Variants with 100% Accuracy

In a study, the RNA-encoded viral nucleic acid analytic reporter correctly determined the Alpha, Gamma, Delta, Epsilon, and Omicron genetic mutations in nasopharyngeal clinical samples.

“The COVID-19 pandemic has created an urgent need for individualized diagnostic tools that can recognize the presence of the virus as well as the particular strain,” says corresponding author John Chaput, professor of pharmaceutical sciences at the University of California, Irvine.

Read the full story here.

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

Subscribe To Our Newsletter

Get updates From the UCI School of Pharmacy and Pharmaceutical Sciences

More To Explore


Hispanic Heritage Month With Emily Castro

Emily Castro, a fourth-year, first-generation student in the PhD in pharmacological sciences program, shares advice to others forging new paths.